Skip to content

Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage

Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage in Children With Obstructive Anuria and Acute Renal Failure Due to Ureteral Calculi: a Prospective, Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02055430
Enrollment
90
Registered
2014-02-05
Start date
2010-03-31
Completion date
2013-09-30
Last updated
2014-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Renal Failure, Children, Obstructive Uropathy, Ureteric Stones

Keywords

anuria, children, nephrostomy, stents, urinary calculi

Brief summary

To compare percutaneous nephrostomy (PCN) versus double J stent (JJ) as an initial urinary drainage in children

Detailed description

To compare percutaneous nephrostomy (PCN) versus double J stent (JJ) as an initial urinary drainage in children with obstructive calcular anuria and acute renal failure due to ureteric calculi to identify selection criteria for initial urinary drainage method to improve drainage, to decrease complications and to facilitate subsequent definitive clearance of stones as this comparison is lacking in literature

Interventions

PROCEDUREpercutaneous nephrostomy insertion

The 1st arm was drained by PCN. This was performed under general anesthesia (GA) and fluoroscopic guidance.

PROCEDUREbilateral double J ureteric stent

The 2nd arm was drained by bilateral JJ . This was performed under general anesthesia (GA) and fluoroscopic guidance.

PROCEDUREDefinitive stone management

(shockwave lithotripsy, chemodissolution therapy, ureteroscopy or open surgery) for clearance of stones.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
No

Inclusion criteria

* children ≤12 years old presenting with Obstructive Anuria and Acute Renal Failure due to bilateral ureteric stones

Exclusion criteria

* Patients with grade 0-1 hydronephrosis * fever, pyonephrosis or sepsis. * any contraindication to both methods of drainage (urinary diversion, urethral stricture or uncontrolled coagulopathy).

Design outcomes

Primary

MeasureTime frameDescription
Period to Return to Normal Creatinine1 weekperiod required for normalization of serum creatinine after initial urinary drainage using percutaneous nephrostomy or ureteric stent in children with obstructive calcular anuria and Acute Renal Failure serum creatinine was compared to normal values in matched healthy children
Complications of Each Drainage Method1 weekcomplications of initial urinary drainage using percutaneous nephrostomy or ureteric stent in children with Obstructive Anuria and Acute Renal Failure (mucosal complications, failure of insertion, slippage, fever and infection, hematuria, leakage) complications were calculated per 45 ureterorenal units in PCN group and 90 ureterorenal units in Double J group

Secondary

MeasureTime frameDescription
The Number of Subsequent Interventions Needed for Clearance of Stones .6 monthsThe number of subsequent interventions needed for clearance of stones after normalization of serum creatinine in relation to initial urinary drainage method using percutaneous nephrostomy or ureteric stent in children with Obstructive Anuria and Acute Renal Failure

Other

MeasureTime frameDescription
Factors Affecting the Outcome of Each Group (Operative Time, Safety and Efficacy)1 weekage, site of stones, size of stones, degree of hydronephrosis they were calculated per 45 ureterorenal units in PCN group and 90 ureterorenal units in Double J group

Countries

Egypt

Participant flow

Participants by arm

ArmCount
Percutaneous Nephrostomy
percutaneous nephrostomy insertion (6-8 Fr in size) for initial urinary drainage followed by definitive stone management. percutaneous nephrostomy insertion: The 1st arm was drained by PCN. This was performed under general anesthesia (GA) and fluoroscopic guidance. Definitive stone management: (shockwave lithotripsy, chemodissolution therapy, ureteroscopy or open surgery) for clearance of stones.
45
Bilateral Double J Ureteric Stents
double J ureteric stent insertion (4.8-6 Fr JJ in size) for initial urinary drainage followed by definitive stone management. bilateral double J ureteric stent: The 2nd arm was drained by bilateral JJ . This was performed under general anesthesia (GA) and fluoroscopic guidance. Definitive stone management: (shockwave lithotripsy, chemodissolution therapy, ureteroscopy or open surgery) for clearance of stones.
45
Total90

Baseline characteristics

CharacteristicPercutaneous NephrostomyBilateral Double J Ureteric StentsTotal
Age, Continuous4.78 years
STANDARD_DEVIATION 2.295
4.07 years
STANDARD_DEVIATION 2.093
4.42 years
STANDARD_DEVIATION 2.213
creatinine4.3 mg/dL
STANDARD_DEVIATION 1.8
4.8 mg/dL
STANDARD_DEVIATION 1.9
4.59 mg/dL
STANDARD_DEVIATION 1.901
hydronephrosis
grade 2
27 participants30 participants57 participants
hydronephrosis
grade 3-4
18 participants15 participants33 participants
radiolucency of stones
patients with radiolucent stones
27 participants28 participants55 participants
radiolucency of stones
patients with radioopaque stones
18 participants17 participants35 participants
Region of Enrollment
Egypt
45 participants45 participants90 participants
Sex: Female, Male
Female
15 Participants11 Participants26 Participants
Sex: Female, Male
Male
30 Participants34 Participants64 Participants
site of stone (180 ureterorenal units)
lower ureter
37 ureterorenal units of participants38 ureterorenal units of participants75 ureterorenal units of participants
site of stone (180 ureterorenal units)
middle ureter
16 ureterorenal units of participants15 ureterorenal units of participants31 ureterorenal units of participants
site of stone (180 ureterorenal units)
upper ureter
37 ureterorenal units of participants37 ureterorenal units of participants74 ureterorenal units of participants
size of stone15.011 mm
STANDARD_DEVIATION 4.22
13.25 mm
STANDARD_DEVIATION 5.37
14.1 mm
STANDARD_DEVIATION 5.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
2 / 451 / 45
serious
Total, serious adverse events
0 / 450 / 45

Outcome results

Primary

Complications of Each Drainage Method

complications of initial urinary drainage using percutaneous nephrostomy or ureteric stent in children with Obstructive Anuria and Acute Renal Failure (mucosal complications, failure of insertion, slippage, fever and infection, hematuria, leakage) complications were calculated per 45 ureterorenal units in PCN group and 90 ureterorenal units in Double J group

Time frame: 1 week

Primary

Period to Return to Normal Creatinine

period required for normalization of serum creatinine after initial urinary drainage using percutaneous nephrostomy or ureteric stent in children with obstructive calcular anuria and Acute Renal Failure serum creatinine was compared to normal values in matched healthy children

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Percutaneous NephrostomyPeriod to Return to Normal Creatinine2.22 daysStandard Deviation 0.765
Bilateral Double J Ureteric StentsPeriod to Return to Normal Creatinine2.18 daysStandard Deviation 0.777
Secondary

The Number of Subsequent Interventions Needed for Clearance of Stones .

The number of subsequent interventions needed for clearance of stones after normalization of serum creatinine in relation to initial urinary drainage method using percutaneous nephrostomy or ureteric stent in children with Obstructive Anuria and Acute Renal Failure

Time frame: 6 months

Other Pre-specified

Factors Affecting the Outcome of Each Group (Operative Time, Safety and Efficacy)

age, site of stones, size of stones, degree of hydronephrosis they were calculated per 45 ureterorenal units in PCN group and 90 ureterorenal units in Double J group

Time frame: 1 week

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026